Answers are grounded in this paper and cite their sources.
Advances in human genomics have accelerated the identification of disease-associated variation, yet the pathway from genomic discovery to meaningful health benefit remains uneven. Translation is especially challenging in communities historically underrepresented in genomic research, where barriers related to trust, access, comprehension, counseling, clinical integration, and social determinants of health can limit the usefulness of genomic information. We propose a five-stage translational framework for equitable genomic medicine: (1) readiness, trust, and genomic orientation; (2) equitable access, return, and interpretation; (3) counseling, education, and meaning-making; (4) behavioral and clinical action; and (5) integration, outcomes, governance, and continuous learning. The framework is grounded in preliminary observations from Linking GAINS, a community-based randomized feasibility study among 60 African American adults in Baton Rouge, Louisiana, that integrated clinical-grade genomic testing with a 14-session cardiovascular health behavior intervention. Genetic counseling was available to all participants, and counseling participation was voluntary and could not be required. Sixteen participants completed a documented counseling session, including all five participants with an identified genetic-risk finding. These observations illustrate the distinction between access, result retrieval, counseling uptake, and participant-reported understanding. The proposed framework extends genomic translation beyond variant identification and result return to include community context, education, meaning-making, behavioral and clinical action, health-system integration, governance, and continuous learning.
No takes yet. Share an insight, caveat, or question.
Caldwell et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: